Hepatitis E virus RNA in Australian blood donors: prevalence and risk assessment.

V C HoadClive R SeedJ J FrykR HarleyR L P FlowerB M HogemaPhilip Kiely Helen M Faddy

Published in: Vox sanguinis (2017)

Hepatitis E virus viremia is rare in Australia and lower than the published RNA prevalence estimates of other developed countries. The risk of TT-HEV adverse outcomes is negligible, and HEV RNA donor screening is not currently indicated.

Keyphrases

risk assessment
risk factors
nucleic acid
systematic review